» Articles » PMID: 38828203

Unlocking the Medicinal Potential of Plant-Derived Extracellular Vesicles: Current Progress and Future Perspectives

Overview
Publisher Dove Medical Press
Specialty Biotechnology
Date 2024 Jun 3
PMID 38828203
Authors
Affiliations
Soon will be listed here.
Abstract

Botanical preparations for herbal medicine have received more and more attention from drug researchers, and the extraction of active ingredients and their successful clinical application have become an important direction of drug research in major pharmaceutical companies, but the complexity of extracts, multiple side effects, and significant individual differences have brought many difficulties to the clinical application of herbal preparations. It is noteworthy that extracellular vesicles as active biomolecules extracted from medicinal plants are believed to be useful for the treatment of a variety of diseases, including cancer, inflammation, regenerative-restorative and degenerative diseases, which may provide a new direction for the clinical utilization of herbal preparations. In this review, we sort out recent advances in medicinal plant extracellular vesicles and discuss their potential as disease therapeutics. Finally, future challenges and research directions for the clinical translation of medicinal plant extracellular vesicles are also discussed, and we expect that continued development based on medicinal plant extracellular vesicles will facilitate the clinical application of herbal preparations.

Citing Articles

-Derived Exosome-Like Nanoparticles Mitigate Colitis in Mice via Inhibition of the NLRP3 Signaling Pathway and Modulation of the Gut Microbiota.

Li J, Xu J, Huang C, Hu J, Xu H, Guo X Int J Nanomedicine. 2025; 19:13991-14018.

PMID: 39742094 PMC: 11687308. DOI: 10.2147/IJN.S493434.


Chinese herbal medicine-derived extracellular vesicles as novel biotherapeutic tools: present and future.

Zhang J, Tian S, Guo L, Zhao H, Mao Z, Miao M J Transl Med. 2024; 22(1):1059.

PMID: 39587576 PMC: 11587639. DOI: 10.1186/s12967-024-05892-3.

References
1.
Tauro B, Greening D, Mathias R, Ji H, Mathivanan S, Scott A . Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. Methods. 2012; 56(2):293-304. DOI: 10.1016/j.ymeth.2012.01.002. View

2.
Teng Y, Ren Y, Sayed M, Hu X, Lei C, Kumar A . Plant-Derived Exosomal MicroRNAs Shape the Gut Microbiota. Cell Host Microbe. 2018; 24(5):637-652.e8. PMC: 6746408. DOI: 10.1016/j.chom.2018.10.001. View

3.
Chen N, Sun J, Zhu Z, Cribbs A, Xiao B . Edible plant-derived nanotherapeutics and nanocarriers: recent progress and future directions. Expert Opin Drug Deliv. 2022; 19(4):409-419. DOI: 10.1080/17425247.2022.2053673. View

4.
Maas S, Breakefield X, Weaver A . Extracellular Vesicles: Unique Intercellular Delivery Vehicles. Trends Cell Biol. 2016; 27(3):172-188. PMC: 5318253. DOI: 10.1016/j.tcb.2016.11.003. View

5.
Lian M, Chng W, Liang J, Yeo H, Lee C, Belaid M . Plant-derived extracellular vesicles: Recent advancements and current challenges on their use for biomedical applications. J Extracell Vesicles. 2022; 11(12):e12283. PMC: 9753580. DOI: 10.1002/jev2.12283. View